Zusammenfassung
Muskeldystrophien bilden eine klinisch und genetisch heterogene Gruppe primär degenerativer, progressiver Muskelerkrankungen. Das Manifestationsalter reicht von der frühen Kindheit bis in das mittlere und späte Erwachsenenalter. Bei vielen Formen ist inzwischen der zugrundeliegende Genort, bei einigen Formen auch das defekte Genprodukt bekannt. Dies hat zu einer neuen Klassifikation der Muskeldystrophien geführt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Zitierte Literatur
Amit R, Bashan N, Abarbanel JM et al. (1992) Fatal familial infantile glycogen storage disease: multisystem phosphofruc-tokinase deficiency. Muscle Nerve 15:455–458
Danon MJ, Carpenter S, Manaligod JR, Schliselfeld LH (1981) Fatal infantile glycogen storage disease: deficiency of phos-phofructokinase and Phosphorylase b kinase. Neurology 31:1303–1307
Danon MJ, Servidei S, DiMauro S, Vora S (1988) Late-onset muscle phosphofructokinase deficiency. Neurology 38: 956–960
DiMauro S, Tsujino S (1994) Nonlysosomal glycogenoses. In: Engel AG, Franzini-Armstrong C (eds) Myology, vol 2. McGraw-Hill, New York, pp 1554–1576
Fishbein WN (1985) Myoadenylate deaminase deficiency: inherited and acquired forms. Biochem Med 33:158–169
Guibaud P, Carrier H, Mathieu M et al. (1978) Observation familiale de dystrophic musculaire congenitale par deficit en phosphofructokinase. Arch Pediatr 35:1105 – 1115
Haller RG, Lewis SF (1991) Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency. N Engl J Med 324:364–369
Hays AP, Hallet M, Delfs J et al. (1981) Muscle phosphofructokinase deficiency: abnormal polysaccharide in a case of late-onset myopathy. Neurology 31:1077–1086
Hers HG, Van Hoof F, Barsy T de (1989) Glycogen storage disease. In: Scriver CR, Beaudet N, Sly WS, Valle D (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 425–452
Ricker K, Koch MC, Lehmann-Horn F, Pongratz D Otto M, Heine R, Moxley RT (1994) Proximal myotonic myopathy: A new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 44:1448–1452
Serratrice G, Monges A, Roux H et al. (1969) Forme myopathique du deficit en phosphofructokinase. Rev Neurol 34:271–277
Servidei S, Bonilla E, Diedrich RG et al. (1986) Fatal infantile form of muscle phosphofructokinase deficiency. Neurology 36:1465–1470
Zierz S (1994) Carnitine palmitoyltransferase deficiency. In: Engel AG, Franzini-Armstrong C (eds) Myology, vol 2. Mc Graw-Hill, New York, pp 1577–1586
Zierz S, Engel AG (1985) Regulatory properties of a mutant carnitine palmitoyl transferase in human skeletal muscle. Eur J Biochem 149: 207–214
Weiterführende Literatur
Barohn RJ, Miller RG, Griggs RC (1991) Autosomal recessive distal dystrophy. Neurology 41:1365 – 1370
Brais B, Xie YG, Sanson M (1995) The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac aand ßmyosin heavy chain genes on chromosome 14qll.2-ql3. Hum Mol Genet 4:429 – 434
Brevister B, Groenen P, Wieringa B (1998) Myotonic dystrophy: clinical and molecular aspects. In: Emery AEH (ed) Neuromuscular disorders: clinical and molecular genetics. Wiley & Sons, Chichester, pp 323 – 364
Brook JD, McCurrach ME, Harley HG et al. (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3’end of a transcript encoding a protein kinase family member. Cell 68: 799–808
Campbell KP (1995) Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80: 675–679
Cox GF, Kunkel LM (1997) Dystrophies and heart disease. Curr Opin Cardiol 12: 329–343
Davies KE (1997) Challenges in Duchenne muscular dystrophy. Neuromuscul Disord 7:482 – 486
DiMauro S (1997) Mitochondrial encephalomyopathies. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL (eds) The molecular and genetic basis of neurological diseases. Butterworth-Heinemannn, Boston Wellington, S 201–235
Eger K, Schulte-Mattler WJ, Zierz S (1997) Proximale myotone Myopathie (PROMM). Nervenarzt 68: 839–844
Emery AEH (ed) (1997) Diagnostic criteria for neuromuscular disorders, 2nd edn. Royal Society of Medicine, London
Emery AEH (ed) (1998) Neuromuscular disorders: clinical and molecular genetics. Wiley & Sons, Chichester
Engel A, Franzini-Armstrong C (eds) (1994) Myology, 2nd edn, vol 1 and 2. McGraw-Hill, New York
Finsterer J (1997) Mitochondriopathien. Akt Neurologie 24: 231–241
Goto YI, Nonaka I, Horai S (1990) A mutation in the tRNA-Leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348:651 – 653
Harper PS (1989) Myotonic dystrophy, 2nd edn. Saunders, Philadelphia
Hirano M, Ricci E, Koenigsberger MR et al. (1992) MELAS: an original case and clinical criteria for diagnosis. Neuromus-cul Disord 2:125–135
Jackson MJ, Schaefer JA, Johnson MA, Morris AAM, Turnbull DM, Bindoff LA (1995) Presentation and clinical investigation of mitochondrial respiratory chain disease. Brain 118: 339–357
Jerusalem F, Zierz S (1991) Muskelerkrankungen, 2. Aufl. Thieme, Stuttgart
Kakulas BA (1996) The differential diagnosis of the human dystrophinopathies and related disorders. Curr Opin Neurol 9:380–388
Lehmann-Horn F, Engel AG, Ricker K, Rudel R (1994) The periodic paralyses and paramyotonia congenita. In: Engel AG, Franzini-Armstrong (eds) Myology, vol 2. McGraw-Hill, New York, pp 1303–1334
Lehmann-Horn F, Mailander V, Heine R, George AL (1995) Myotonia levior is a chloride channel disorder. Hum Mol Genet 4:1397–1402
Lim LE, Campbell KP (1998) The sarcoglycan complex in limb-girdle muscular dystrophy. Curr Opin Neurol 11:443 – 452
Liu J, Aoki M, Ilia I et al. (1998) Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 20: 31 – 36
Manilal S, Recan D, Sewry CA et al. (1998) Mutations in Emery-Dreifuss muscular dystrophy and their effects on emerin protein expression. Hum Mol Genet 7: 855–864
Meyer-Kleine C, Steinmeyer K, Ricker K, Jentsch T, Koch MC (1995) Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCNI) leading to myotonia. Am J Hum Genet 57: 1325–1334
Mortier W (1994) Muskel- und Nervenerkrankungen im Kindesalter. Thieme, Stuttgart New York
Pongratz DE, Reimers CD, Hahn D, Nägele M, Müller-Felber W (1990) Atlas der Muskelkrankheiten. Urban & Schwarzen-berg, München
Ricker K, Koch MC, Lehmann-Horn F, Pongratz D, Speich N, Reiners K, Schneider C, Moxley RT (1995) Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurol 52: 25–31
Riordan-Eva P, Wood NW (1996) Mitochondrial disorders in neuro-ophthalmology. Curr Opin Neurol 9:1–4
Rosenfeld J, Sloanbrown K, George AL (1997) A novel muscle sodium channel mutation causes painful congenital myotonia. Ann Neurol 42:811–814
Rudel R, Lehmann-Horn F (1998) Muscle ion channel diseases: non-dystrophic myotonias, periodic paralyses, and malignant hyperthermia. In: Emery AEH (ed) Neuromuscular disorders: clinical and molecular genetics. Wiley & Sons, Chichester, pp 365 – 420
Schapira AHV, DiMauro S (eds) (1994) Mitochondrial disorders in Neurology. Butterworth-Heinemann, Oxford
The FSH-DY Group (1997) A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. Neurology 48:38–46
Voit T, Krogmann O, Lenard HG et al. (1988) Emery-Dreifuss muscular dystrophy: disease spectrum and differential diagnosis. Neuropediatrics 19:62–71
Wallace DC, Singh G, Lott MT (1988) Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science 242:1427–1430
Wallgren-Petterson C (1998) Genetics of the Nemaline myopathies and the myotubular myopathies. Neuromuscul Disord 8:401–404
Wewer UM, Engvall E (1996) Merosin/Laminin-2 and muscular dystrophy. Neuromuscul Disord 6:409 – 418
Wijmenga C, Frants RR, Brouwer OF et al. (1990) Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet 336: 651–653
Zierz S, Jerusalem F (1989) Mitochondriale Myopathien und Enzephalomyopathien. Nervenarzt 60:394 – 400
Zierz S, Meeßen S, Jerusalem F (1989) Laktat- und Pyruvat-blutspiegel in der Diagnostik mitochondrialer Myopathien. Nervenarzt 60: 545–548
Zierz S, Wersebe O von, Gerbitz KD, Jerusalem F (1990) Ophthalmoplegia plus: klinische Variabilität, biochemische Defekte der mitochondrialen Atmungskette und Deletionen des mitochondrialen Genoms. Nervenarzt 61: 332–339
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Eger, K., Schulte-Mattler, W.J., Hertel, K., Deschauer, M., Lindner, A., Zierz, S. (1999). Muskeldystrophien, Myotonien und metabolische Myopathien Bearbeitet. In: Berlit, P. (eds) Klinische Neurologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-08118-1_10
Download citation
DOI: https://doi.org/10.1007/978-3-662-08118-1_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-08119-8
Online ISBN: 978-3-662-08118-1
eBook Packages: Springer Book Archive